Business Segments Thermo Fisher Scientific, Inc. Xetra
Equities
TN8
US8835561023
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 458.80 EUR | +0.57% |
|
-6.47% | -7.12% |
| Feb. 10 | Thermo Fisher Scientific Prices $3.8 Billion Senior Notes | MT |
| Feb. 10 | Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes | CI |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Measuring, Analyzing, and Controlling Instruments | ||||||||||
Laboratory Products and Biopharma Services | 12.24B | 14.86B | 22.51B | 23.04B | 23.16B | |||||
Total Assets | 22.71B | 52.64B | 51.28B | 51.09B | 6.14B | |||||
CAPEX | -772M | -1.33B | -1.4B | -1.01B | -971M | |||||
D&A | 342M | 423M | 614M | 669M | 721M | |||||
Operating Income | 1.27B | 1.84B | 2.87B | 3.36B | 3.09B | |||||
Analytical Instruments | 5.12B | 6.07B | 6.62B | 7.26B | 7.46B | |||||
Total Assets | 9.77B | 9.69B | 10.02B | 10.25B | 2.94B | |||||
CAPEX | -74M | -79M | -140M | -87M | -95M | |||||
D&A | 76M | 83M | 83M | 93M | 103M | |||||
Operating Income | 808M | 1.2B | 1.51B | 1.91B | 1.96B | |||||
Life Sciences Tools and Services | ||||||||||
Life Sciences Solutions | 12.17B | 15.63B | 13.53B | 9.98B | 9.63B | |||||
Total Assets | 20.21B | 22.75B | 21.85B | 20.19B | 2.98B | |||||
CAPEX | -392M | -810M | -490M | -178M | -123M | |||||
D&A | 140M | 197M | 214M | 220M | 230M | |||||
Operating Income | 6.11B | 7.82B | 5.58B | 3.42B | 3.5B | |||||
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Specialty Diagnostics | 5.34B | 5.66B | 4.76B | 4.4B | 4.51B | |||||
Total Assets | 6.53B | 6.01B | 5.54B | 8.64B | 1.22B | |||||
CAPEX | -175M | -167M | -112M | -121M | -125M | |||||
D&A | 100M | 128M | 75M | 86M | 104M | |||||
Operating Income | 1.37B | 1.28B | 1.02B | 1.12B | 1.16B | |||||
Unallocated Amounts | - | - | - | - | - | |||||
Total Assets | 9.82B | 4.03B | 8.46B | 8.56B | 84.03B | |||||
CAPEX | -61M | -140M | -98M | -80M | -85M | |||||
Operating Income | - | - | - | - | - | |||||
Eliminations | -2.66B | -3.01B | -2.52B | -1.83B | -1.88B |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 16.44B | 18.91B | 23.82B | 22.01B | 21.76B | |||||
Total Assets | 3.69B | 5.58B | 6.31B | 6.35B | 6.24B | |||||
Other Regions | 12.99B | 16.86B | 17.3B | 20.84B | 21.12B | |||||
Total Assets | 3B | 4.29B | 4.56B | 4.65B | 4.55B | |||||
Japan | - | - | - | - | - | |||||
China | 2.8B | 3.44B | 3.79B | - | - | |||||
United Kingdom | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Germany | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - |
Select your edition
All financial news and data tailored to specific country editions
